The TOAD trial: follow-up data on quality of life

Some 15 months ago, we reported the initial, primary results of the TOAD trial, which showed an overall survival benefit for immediate as opposed to delayed initiation of androgen deprivation therapy (ADT) in non-metastatic patients considered to be inappropriate for curative therapy. … READ MORE …

Real care beyond medical treatment, and impact on quality of life

A small, recent pilot study in Geneva, Switzerland, has shown that radiation therapy (RT) + androgen deprivation therapy (ADT) can be given safely to frail patients with non-metastatic, locally advanced or aggressive, intermediate prostate cancer, if and when a multidisciplinary care program is implemented to help such frail patients to limit risk for and manage predictable side effects. … READ MORE …

“And now for something completely different”: a soccer-based clinical trial

As some older readers may remember, the phrase “And now for something completely different” was a recurring introduction to the next form of surreal madness on “Monty Python’s Flying Circus” (although its origins precede Monty Python). … READ MORE …

Patient-reported outcomes and quality of life in the ProtecT trial

We have already commented on the oncologic outcomes of patients enrolled in the ProtecT trial and published in today’s issue of the New England Journal of Medicine. In this commentary we shall comment on the separate paper that addresses patient-reported outcomes from that trial. … READ MORE …

Long-term quality of life for men on active surveillance

According to a paper presented today at the annual meeting of the European Association of Urology (EAU) in Munich, Germany, men on a structured active surveillance (AS) protocol have a high, long-term quality of life on follow-up. … READ MORE …

What’s happening at the annual EAU meeting in Munich?

So our friends at UroToday have started providing reports on the key presentations that are being given at the annual meeting of the European Association of Urology, being held this year in Munich, Germany. Here are links to some interesting reports … READ MORE …

Patients’ sexual orientation and communication with healthcare providers

The ability and willingness of physicians to discuss issues related to sex, sexual function, and specific sexual activities with their patients (and their partners) before or after prostate cancer treatment is notoriously not seen to be high by most prostate cancer patients (although there are exceptions to that general rule). … READ MORE …